Il‐Kang Na

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 540 citations · Full text

Medicine, Clinical Sciences, Immunology +16

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells

Quirin Hammer, Timo Rückert, Eva Maria Borst et al. · Nature Immunology · 2018 · 414 citations

Life Sciences, Immunology, Microbiology +15

Chemokine Receptor CCR6 Expression Level and Liver Metastases in Colorectal Cancer

Pirus Ghadjar, Sarah E. Coupland, Il‐Kang Na et al. · Journal of Clinical Oncology · 2006 · 126 citations

Medicine, Oncology, Pathology +17

NOD2 regulates hematopoietic cell function during graft-versus-host disease

Olaf Penack, Odette M. Smith, Amy Cunningham‐Bussel et al. · The Journal of Experimental Medicine · 2009 · 106 citations · Full text

Life Sciences, Immunology, Pathology +17

Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique

K.‐A. Kreuzer, Philipp le Coutre, Olfert Landt et al. · Annals of Hematology · 2003 · 87 citations

Medicine, Molecular Biology, Oncology +12